Amendment No. 1 to Research, License and Option Agreement (“Amendment No. 1”)Research, License and Option Agreement • March 12th, 2018 • Wave Life Sciences Ltd. • Pharmaceutical preparations
WHEREAS, the parties hereto desire to amend certain terms of the Agreement in order to provide for an extension of the period of time to nominate the Additional Programs,
